0001181431-12-029998.txt : 20120515 0001181431-12-029998.hdr.sgml : 20120515 20120515171218 ACCESSION NUMBER: 0001181431-12-029998 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120514 FILED AS OF DATE: 20120515 DATE AS OF CHANGE: 20120515 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Siegel Eric H. CENTRAL INDEX KEY: 0001527573 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-12400 FILM NUMBER: 12845927 MAIL ADDRESS: STREET 1: ROUTE 141 & HENRY CLAY RD., BLDG. E336 STREET 2: C/O INCYTE CORP., EXPERIMENTAL STATION CITY: WILMINGTON STATE: DE ZIP: 19880 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: INCYTE CORP CENTRAL INDEX KEY: 0000879169 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731] IRS NUMBER: 943136539 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ROUTE 141 & HENRY CLAY ROAD STREET 2: BUILDING E336 CITY: WILMINGTON STATE: DE ZIP: 19880 BUSINESS PHONE: 3024986700 MAIL ADDRESS: STREET 1: ROUTE 141 & HENRY CLAY ROAD STREET 2: BUILDING E336 CITY: WILMINGTON STATE: DE ZIP: 19880 FORMER COMPANY: FORMER CONFORMED NAME: INCYTE CORP DATE OF NAME CHANGE: 20030318 FORMER COMPANY: FORMER CONFORMED NAME: INCYTE GENOMICS INC DATE OF NAME CHANGE: 20000710 FORMER COMPANY: FORMER CONFORMED NAME: INCYTE PHARMACEUTICALS INC DATE OF NAME CHANGE: 19930902 4 1 rrd345262.xml X0305 4 2012-05-14 0 0000879169 INCYTE CORP INCY 0001527573 Siegel Eric H. EXPERIMENTAL STATION ROUTE 141 AND HENRY CLAY RD WILMINGTON DE 19880 0 1 0 0 EVP, General Counsel Common Stock 2012-05-14 4 M 0 8002 16.66 A 8817 D Common Stock 2012-05-14 4 M 0 31997 16.66 A 40814 D Common Stock 2012-05-14 4 M 0 16667 14.72 A 57481 D Common Stock 2012-05-14 4 S 0 56666 23.12 D 815 D Common Stock 2012-05-14 4 S 0 100 23.12 D 715 D Common Stock 2012-05-14 4 S 0 715 23.11 D 0 D Incentive Stock Option (right to buy) 16.66 2012-05-14 4 M 0 8002 0 D 2017-10-28 Common Stock 8002 10004 D Non-Qualified Stock Option (right to buy) 16.66 2012-05-14 4 M 0 31997 0 D 2017-10-28 Common Stock 31997 29997 D Non-Qualified Stock Option (right to buy) 14.72 2012-05-14 4 M 0 16667 0 D 2018-01-24 Common Stock 16667 22221 D Reporting person undertakes to provide upon request by the Securities and Exchange Commission, the issuer or a securityholder of the issuer detailed information regarding the price and number of shares sold within the range indicated. Represents weighted average sale price. Actual sale prices ranged from $23.05 to $23.15. Beginning October 29, 2010, options become exercisable in 25 installments, with the first intallment of 33.33% vesting after one year and the remaining vesting monthly over two years. Beginning January 25, 2011, options become exercisable in 25 installments, with the first intallment of 33.33% vesting after one year and the remaining vesting monthly over two years. /s/ Eric Siegel 2012-05-15